Room for improvement in Sweden's device regulations, says SOS
This article was originally published in Clinica
Quality and security within the Swedish medical device industry is generally high, yet procedures need to be made still more efficient, claims the national board of health and welfare (SOS). In its annual report for 2000, SOS has laid out a framework towards achieving its aim of making products safer, while achieving optimal use and ensuring that they are used correctly.
You may also be interested in...
A Phase III trial testing the antibody-drug conjugate sacituzumab govitecan was stopped early for efficacy, boding well for the BLA pending at the US FDA.
Deal Snapshot: Six companies seek to collect convalescent plasma from COVID-19 survivors to quickly develop hyperimmune immunoglobulin therapy for serious complications of the virus.
Pharmaceutical companies struggling to keep up with coronavirus-related supply chain havoc asked to keep the US regulator informed as situation unfolds.